Cytek Biosciences, Inc.: Business Overview, Financials & Competitive Analysis
Cytek Biosciences, Inc. scores 6/10 on the AskCyborg Cyborg Score (Solid). Cytek demonstrates improving profitability with stable modest revenue growth powered by full-spectrum flow cytometry innovation and expanding global reach. 2024 revenue was $200.45 million with 3.85% year-over-year growth, while losses improved significantly to -$6.02 million, 50.44% less than in 2023. Full-year 2025 revenue is expected to reach approximately $201.
What is Cytek Biosciences, Inc.'s industry? Cytek Biosciences, Inc. (cytekbio.com) operates in Analytical Laboratory Instrument Manufacturing / Life Sciences Technology / Flow Cytometry. AskCyborg classifies Cytek Biosciences, Inc. under Analytical Laboratory Instrument Manufacturing / Life Sciences Technology / Flow Cytometry in its company registry.
Cytek Biosciences is a cell analysis solutions company that provides cell analysis tools facilitating scientific advances in biomedical research and clinical applications. The company focuses on delivering high-resolu...
Cyborg Score thesis
Cytek demonstrates improving profitability with stable modest revenue growth powered by full-spectrum flow cytometry innovation...
Read the full analyst-debate transcript →Get the Latest Cytek Biosciences, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeCytek Biosciences, Inc. Overview
Pro stress-test →Cytek Biosciences is a cell analysis solutions company that provides cell analysis tools facilitating scientific advances in biomedical research and clinical applications. The company focuses on delivering high-resolution, high-content and high-sensitivity cell analysis using its patented Full Spectrum Profiling™ (FSP®) technology.
Strategic Profile
Pro stress-test →The FSP platform addresses limitations of other technologies by providing higher-density information with greater sensitivity, more flexibility and increased efficiency. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations, with direct sales force and support in North America, Europe, China, and Asia-Pacific regions.
Competitive Landscape
Pro stress-test →Competitors include Imperial Life Sciences, TerumoBCT, Active Motif, Treefrog Therapeutics, and FluoroFinder. Cytek faces competition from legacy providers and must navigate complex regulatory environments to secure clinical certifications.
Industry Context
Cytek Biosciences, Inc. operates in Analytical Laboratory Instrument Manufacturing / Life Sciences Technology / Flow Cytometry.
Key facts
Founded: 1992 · Headquarters: Fremont, US · Revenue: $200.45M (2024) · Market cap: $640.6M